Radical lymph node dissection for melanoma

ANZ Journal of Surgery

Volumn 73, Issue 5, 2003, Pages 294-299

  Serpell, Jonathan W ^a,b   Carne, Peter W G ^a   Bailey, Michael ^a  

^a MONASH UNIVERSITY   (Australia)

^b NONE   (Australia)

Author keywords

Cancer; Lymphadenectomy; Melanoma; Regional nodal recurrence; Surgery; Therapeutic node dissection

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CERVICAL LYMPH NODE; DRAIN; FEMALE; HUMAN; INFECTION RATE; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; LYMPHADENECTOMY; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MORBIDITY; RADICAL LYMPH NODE DISSECTION; RECURRENCE RISK; RISK FACTOR; SEROMA; TUMOR VOLUME; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SKIN DISEASES; SURGICAL WOUND INFECTION; SURVIVAL RATE;

EID: 0038694572     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2003.t01-1-02622.x     Document Type: Article

References (37)

1. Jelfs PL, Giles GG, Shugg D et al. Cutaneous melanoma in Australia, 1989. Med. J. Aust. 1994; 161: 182-7.
2. McCarthy WH, Shaw HM. The influence of prognostic factors on melanoma management. In: Lejeune FJ, Chaudhuri PK, Das Gupta TK (eds). Malignant Melanoma. New York: McGraw-Hill, 1994; pp. 171-85.
3. Balch CM, Soong SJ, Shaw HM. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW et al. (eds). Cutaneous Melanoma. Philadelphia: Lippincott, 1992; pp. 165-87.
4. Karakousis CP. Therapeutic node dissections in malignant melanoma. Ann. Surg. Oncol. 1998; 5: 473-82.
5. Shaw JHF, Rumball EM. Complications and local recurrence following lymphadenectomy. Br. J. Surg. 1990; 77: 760-4.
6. Karakousis CP, Driscoll DL. Groin dissection in malignant melanoma. Br. J. Surg. 1994; 81: 1771-4.
7. Jonk A, Kroon BBR, Rumke P, van der Esch EP, Hart AAM. Results of radical dissection of the groin in patients with Stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both. Surg. Gynecol. Obstet. 1998; 167: 28-32.
8. Stone CA, Goodacre TEE. Surgical management of regional lymph nodes in primary cutaneous malignant melanoma. Br. J. Surg. 1995; 82: 1015-22.
9. Karakousis CP, Hena MA, Emrich LJ, Driscoll DL. Axillary node dissection in malignant melanoma: results and complications. Surgery 1990; 108: 118-19.
10. Urist MM, Maddox WA, Kennedy JE, Balch CM. Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. Cancer 1983; 51: 2152-6.
11. Burmeister BH, Smithers BM, Davis S et al. Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity. ANZ J. Surg. 2002; 72: 344-8.
12. Karakousis CP, Goumas W, Rao U, Driscoll DL. Axillary node dissection in malignant melanoma. Am. J. Surg. 1991; 162: 202-7.
13. Meyer T, Merkel S, Gohl J, Hohenberger W. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur. J. Surg. Oncol. 2002; 28: 424-30.
14. Thompson JF, Waugh RC, Saw RPM et al. Isolated limb infusion with melphalan for recurrent limb melanoma: a simple alternative to isolated limb perfusion. Regional Cancer Treatment 1994; 7: 188-92.
15. Australian Cancer Network. Guidelines for the Management of Cutaneous Melanoma. Epping: The Stone Press, 1997.
16. Hughes TMD, Thomas JM. Combined inguinal and pelvic lymph node dissection for Stage II melanoma. Br. J. Surg. 1999; 86: 1493-8.
17. Hughes TMD, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br. J. Surg. 2000; 87: 892-901.
18. Mann GB, Coit DG. Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes. Ann. Surg. Oncol. 1999; 6: 263-71.
19. O'Brien CJ, Gianoutsos MP, Morgan MJ. Neck dissection for cutaneous malignant melanoma. World J. Surg. 1992; 16: 222-6.
20. O'Brien CJ, Petersen-Schaefer K, Ruark D, Coates AJ, Menzie SJ, Harrison RI. Radical, modified and selective neck dissection for cutaneous malignant melanoma. Head Neck 1995; 17: 232-41.
21. Morgan RH, Horgan K, Hughes LE. Use of myocutaneous flaps for primary cover following lymph node dissection for malignant melanoma. Br. J. Surg. 1988; 75: 65-8.
22. Ang KK, Peters LJ, Weber RS et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int. J. Radiat. Oncol. Biol. Phys. 1994; 30: 795-8.
23. Coit DG, Rogatko A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. Ann. Surg. 1991; 214: 627-36.
24. Bevilacqua RG, Coit DG, Rogatko A, Younes RN, Brennan MF. Axillary dissection in melanoma. Ann. Surg. 1990; 212: 125-31.
25. Fisher SR. Elective, therapeutic and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970-1998. Laryngoscope 2002; 112: 99-110.
26. Sainsbury R, Haward B, Rider L et al. Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet 1995; 345: 1265-70.
27. Strobbe LJ, Jonk A, Hart AA, Nieweg OE, Kroon BB. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann. Surg. Oncol. 1999; 6: 230-1.
28. Petrek JA, Blackwood MM. Axillary dissection: current practice and technique. Curr. Probl. Surg. 1995; 32: 257-323.
29. Baas PC, Schraffordt Koops H, Hoekstra HJ, Van Bruggen JJ, Van der Weele LT, Oldhoff J. Groin dissection in the treatment of lower extremity melanoma. Short-term and long-term morbidity. Arch. Surg. 1992; 127: 282-6.
30. Sterne GD, Murray DS, Grimley RP. Ilioinguinal block dissection for malignant melanoma. Br. J. Surg. 1995; 82: 1057-9.
31. Warso MA, Das Gupta TK. Melanoma recurrence in a previously dissected lymph node basin. Arch. Surg. 1994; 129: 252-5.
32. Monsour PD, Sanse WT, Avent JM, Noyes RD. Local control following therapeutic nodal dissection for melanoma. J. Surg. Oncol. 1993; 54: 18-22.
33. Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia C, Kraybill WG. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2000; 46: 467.
34. Singletary SE, Shallenberger R, Guinee VF. Surgical management of groin nodal metastases from primary melanoma of the lower extremity. Surg. Gynecol. Obstet. 1992; 174: 195-200.
35. Gadd MA, Coit DG. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma. Arch. Surg. 1992; 127: 1412-16.
36. Kretschmer L, Neumann C, Preusser KP, Marsh WC. Superficial inguinal and radical ilio-inguinal lymph node dissection in patients with palpable melanoma metastases to the groin - an analysis of survival and local recurrence. Acta Oncol. 2001; 40: 72-8.
37. White RR, Tyler DS. Management of node-positive melanoma in the era of sentinel node biopsy. Surg. Oncol. 2000; 9: 119-25.